Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/2/24 20:33 | 4/1/24 | CALC | Health | Drug | Pharmaceutical Preparations | Roberts Eric W | CA | DOT | CHIEF BU | 15 | P.m | 217 | 3.31 | 0 | 65 | 8 | 906 | I | ||||||||||||||
1/25/24 20:00 | 1/23/24 | CALC | Health | Drug | Pharmaceutical Preparations | Middleton Fred A | CA | DT | 4 | P.dm | 2,552 | 3.69 | 0 | 691 | 42 | 2,323 | I | |||||||||||||||
1/25/24 20:00 | 1/23/24 | CALC | Health | Drug | Pharmaceutical Preparations | Sanderling Venture Partners VI LP | CA | T | 1 | P.d | 2,515 | 3.70 | 0 | 679 | 42 | 2,303 | M | |||||||||||||||
12/13/23 20:45 | 12/11/23 | CALC | Health | Drug | Pharmaceutical Preparations | Wilson Robert N | CA | D | 1 | P | 2 | 3.30 | 0 | 1 | 0 | 182 | D | |||||||||||||||
11/8/23 20:42 | 11/7/23 | CALC | Health | Drug | Pharmaceutical Preparations | Leheny A. Rachel | CA | DOT | CEO | 11 | P.m | 76 | 3.64 | 0 | 21 | 3 | 759 | D | ||||||||||||||
11/7/23 18:08 | 11/3/23 | CALC | Health | Drug | Pharmaceutical Preparations | Hebbar Sudarshan | CA | O | Chief Me | 2 | P | 126 | 2.73 | 0 | 46 | 46 | D | |||||||||||||||
6/1/23 19:48 | 5/30/23 | CALC | Health | Drug | Pharmaceutical Preparations | Bjerkholt Eric | CA | D | 4 | P.m | 7 | 2.98 | 0 | 2 | 158 | 4 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |